Small Cap DVLP Getting Traction as Disruptive Roll-Up Play in Emerging Billion Dollar Niche

The specialty pharmacy space is a particularly interesting opportunity as a “disruption” investment theme.

According to recent analysis from Research and Markets, the Global Specialty Drug Distribution Market is projected to reach nearly $4 billion by 2027, growing from just over $1.8 billion at a CAGR of more than 14% over coming years.

Some newer and potentially more effective drugs may not be as profitable for the traditional pharmacy industry or may not be fully covered by most health plans yet. While your doctor may believe it’s the right treatment for you, you may not be able to find it at your local traditional pharmacy and may be given a substitute that’s less effective.

Specialty pharmacies step in to fill that need.

But the specialty pharmacy space is fragmented – it’s dominated by small mom-and-pop shops with no real industry-wide vision. In other words, there’s a ton of value to be harvested by a targeted investment of strategic capital – a coordinated roll-up strategy.

 

The Only Game in Town

Enter Golden Developing Solutions Inc. (OTCMKTS:DVLP), which bills itself as an emerging fully reporting company in the Health, Wellness, Pharmacy and Medical Industry. However, a deeper glance suggests this is an aggressive roll-up model focusing mostly on the specialty pharmacy space, which is not only bigger than you might think but remarkably underserved.

This is a penny stock trading on a $6 million market cap with a leading-edge position in what amounts to a winner-take-all game of industry consolidation in a multi-billion-dollar playing field.

And DVLP has already made strong progress towards positioning itself for this opportunity, making aggressive acquisition moves over the past few months.

In its most recent release, the company announced that it closed its 3rd and 4th acquisition in the past two months. The Company announced it closed its 3rd and 4th acquisitions into the holidays, with its acquisition of Bushnell Pharmacy LLC, a Florida LLC on October 7, 2022, and Sai Siva Healthcare, LLC, a Florida LLC, on that same date.

According to its release, both transactions were Asset Purchase & Sale Agreements.

Stavros Triant, the company’s CEO, noted, “With 4 acquisitions now completed, the company projects revenues can be in excess of $100m per year. We believe that these acquisitions will provide an increasing growth of revenues in this and coming years.”

According to the release, the purchase Price for the Bushnell Pharmacy agreement was $2,250,000, which included inventory of $550,000, Prescription Files (RX Data) of $1,690,000 and the Seller’s non-compete contribution of $10,000.

The purchase Price for the Sai Siva agreement was $3,050,000, which included inventory of $650,000, Prescription Files (RX Data) of $2,390,000 and the Seller’s non-compete contribution of $10,000.

As discussed, the company had previously announced the first two acquisitions – both asset purchase and sale agreements – with COD Management (d/b/a Orchard Trails Pharmacy) on September 23, 2022, and Jai Chamunda New Hudson on September 28, 2022.

In addition, on November 8, the company put out a press release titled, “Golden Developing Solutions Inc (OTC:DVLP) Announces Execution of LOI With $106mil/Yr Revenue Acquisition”.

 

Eyeballs Matter

This is a complicated strategy in an emerging marketplace that most investors may not be watching closely. But DVLP has been forging ahead with its strategy and has already laid a strong foundation. The fact that the stock hasn’t really reacted yet shouldn’t come as a surprise. It’s under the radar.

However, DVLP is starting to get some attention, which could change that state of affairs.

As it has recently announced, the company was recently featured on Newsmax, Fox Business, and Bloomberg TV on FMW Media’s “New To The Street” profile platform, one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programs running today.

Through its network of syndication, FMW programming reaches an estimated 540 million homes across US and international markets.

According to the interview, the company is moving to secure additional acquisition deals as well as investments in its infrastructure to handle future growth and increased operational complexity as the model scales up. That makes for a solid small-cap story in a major growth niche that appears to be getting traction as a media narrative.

For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.